Lyell Immunopharma (LYEL) Q2 2026 Earnings

May 6Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-3.6
-2.77
-1.93
-1.1

Details

Expected EPS
-1.311667
Actual EPS
-1.1
Surprise EPS
0.21
Surprise Percent
+16.14%

Description

⁨Lyell Immunopharma⁩ (⁦LYEL⁩) has reported earnings of ⁦-1.1⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts